Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis.

Front Pharmacol · 2022 · PMC8960447 · PMID 35359852

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

These case studies included a high proportion of ANCA-positive EGPA cases, and, four of the ANCA-positive patients showed a decreasing trend in MPO-ANCA during treatment with benralizumab ( Takenaka et al., 2019 ; Guntur et al., 2021 ; Kolios et al., 2021 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.